Initial Laboratory Workup for Suspected Cancer
The initial laboratory workup for suspected cancer should include a complete blood count (CBC) with differential, comprehensive metabolic panel (including liver function tests, serum calcium, lactate dehydrogenase, and serum creatinine), coagulation profile, and urinalysis. 1
Core Laboratory Tests
Complete Blood Count (CBC) with Differential
- White blood cell count with differential
- Hemoglobin and hematocrit
- Platelet count
- Red blood cell indices
- Peripheral blood smear examination
Comprehensive Metabolic Panel
- Serum calcium (critical for detecting hypercalcemia of malignancy)
- Liver function tests (AST, ALT, alkaline phosphatase, bilirubin)
- Lactate dehydrogenase (LDH) - important prognostic marker
- Serum creatinine and BUN for kidney function
- Electrolytes
- Albumin (nutritional status and prognostic indicator)
Additional Essential Tests
- Coagulation profile (PT, PTT, INR)
- Urinalysis (to detect hematuria or proteinuria)
Imaging Studies
After laboratory tests, appropriate imaging studies should be ordered based on suspected cancer type:
- CT scan of chest, abdomen, and pelvis with contrast is the standard initial imaging for most suspected cancers 2
- FDG-PET/CT for suspected advanced or metastatic disease 2
- Site-specific imaging based on symptoms (e.g., brain MRI for neurological symptoms)
Disease-Specific Laboratory Tests
Hematologic Malignancies
- Bone marrow aspiration and biopsy with:
- Morphologic assessment
- Cytochemical studies
- Immunophenotyping
- Cytogenetic analysis (minimum 20 metaphase cells)
- Molecular studies 1
- Flow cytometry (minimum 3-4 colors, preferably 6-10 colors) 1
Solid Tumors
- Tumor markers as appropriate for suspected cancer type
- Tissue biopsy for histopathological examination
- Molecular testing for targetable mutations
Special Considerations
Kidney Cancer
For suspected kidney cancer, laboratory evaluation should include:
- CBC
- Comprehensive metabolic panel (including serum calcium, liver function studies, LDH, and serum creatinine)
- Coagulation profile
- Urinalysis 2
Gastrointestinal Cancers
For suspected gastric cancer:
- CBC
- Comprehensive chemistry profile
- Esophagogastroduodenoscopy with biopsy 2
Lymphoproliferative Disorders
For suspected lymphoma:
- CBC with differential
- Blood chemistry including LDH
- β2-microglobulin (particularly for follicular and mantle cell lymphomas)
- Serology for HIV, hepatitis B and C 1
Diagnostic Thresholds and Interpretation
- Multiple abnormal blood tests increase the probability of cancer diagnosis 3
- Specific combinations of two abnormal blood tests can indicate a 23-62% probability of cancer 3
- However, most single abnormal blood tests are not specific to cancer and should be interpreted cautiously 3
Common Pitfalls to Avoid
- Delayed diagnosis due to inadequate initial workup
- Overreliance on normal blood tests to rule out cancer (blood tests alone cannot definitively exclude malignancy)
- Failure to perform appropriate tissue sampling when indicated
- Missing occult malignancy by not conducting comprehensive testing
- Inadequate molecular profiling that may miss targetable mutations
By following this structured approach to initial cancer workup, clinicians can ensure appropriate diagnostic evaluation while avoiding unnecessary tests, ultimately improving patient outcomes through timely diagnosis and treatment.